ESGO共识声明:子宫内膜癌预防、风险降低策略及Lynch综合征女性管理
欧洲妇科肿瘤学会(ESGO)组织多学科专家制定循证共识,涵盖Lynch综合征携带者的遗传与癌症风险咨询、筛查、降低风险的手术与药物策略及生殖问题。
要点
- 共识涵盖Lynch综合征相关的子宫内膜癌和卵巢癌风险评估与咨询。
- 推荐降低风险的 surgical 和 medical 策略,并关注携带者生殖问题。
核心结论
- ESGO发布共识声明,标准化Lynch综合征携带者的管理,包括遗传咨询、筛查和风险降低策略。
临床怎么用
- 临床可依据共识声明对Lynch综合征携带者进行标准化管理,包括遗传咨询、癌症筛查和风险降低干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Lynch syndrome (LS) is a hereditary condition associated with an increased susceptibility to developing cancer, primarily colorectal and gynaecological cancer (endometrial cancer and ovarian cancer). The European Society of Gynaecological Oncology (ESGO) nominated fifteen practicing multidisciplinary clinicians with expertise in this field and ten gynaecological and oncological fellows with interest in the topics to develop evidence-based statements, sharing and standardizing the management of LS carriers. Published evidence was integrated with clinical experience to reach Consensus Statements through anonymous voting. In this Consensus, thirty-one statements based on the best available evidence and expert agreement are offered. They focused on genetic and cancer risk counseling principles, screening procedures, risk-reducing surgical and medical strategies, and address emerging topics such as reproductive issues for LS carriers, which are important in current practice. This manuscript reports the Statements that reached a consensus, their voting results, and a summary of supporting evidence.
引用
- Marchetti C, Gultekin M, Sassu CM, et al. ESGO Consensus Statement on endometrial cancer prevention, risk reduction strategies, and management of women with Lynch syndrome. Eur J Cancer. 2026. PMID: 42090914. doi:10.1016/j.ejca.2026.116739
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。